Related Experiment Videos
Lecithin cholesterol acyltransferase activity in chronic nephropathies
Physiologia Bohemoslovaca
|January 1, 1984
Summary
Cholesterol metabolism disturbance, indicated by reduced fractional esterification rate (FER), is detectable even in early stages of chronic kidney disease. This finding is crucial for understanding renal disease progression and cholesterol changes.
Area of Science:
- Nephrology
- Biochemistry
- Clinical Chemistry
Background:
- Chronic renal diseases significantly impact patient health.
- Cholesterol metabolism plays a role in kidney function.
- Previous research suggests links between renal impairment and lipid profiles.
Purpose of the Study:
- To investigate cholesterol metabolism disturbances in patients with chronic renal diseases.
- To determine if reduced fractional esterification rate (FER) is an early indicator of kidney dysfunction.
Main Methods:
- Analysis of serum creatinine, total cholesterol (TCH), molar esterification rate (MER), and fractional esterification rate (FER) in 55 patients with chronic renal diseases.
- Comparison of lipid parameters between patients undergoing haemodialysis and those with varying degrees of preserved kidney function.
Main Results:
- Total cholesterol (TCH) and molar esterification rate (MER) decreased as renal function declined.
- Reduced fractional esterification rate (FER) was observed in approximately two-thirds of dialysed patients and half of those with preserved kidney function.
- Reduced FER indicates a disturbance in cholesterol metabolism.
Conclusions:
- Reduced fractional esterification rate (FER) is an early marker for cholesterol metabolism disturbances in chronic kidney disease.
- These metabolic changes can be detected even in the early stages of nephropathies.
- Monitoring FER may aid in the early diagnosis and management of chronic renal diseases.